Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

The Nicosia criminal court decided on Thursday that Israeli land developer Simon Aykut, charged with the usurpation of Greek ...

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

In the post-op SAKK 09/10 trial, only patients in the higher PORTOS score group benefited from radiation therapy dose escalation (clinical progression free survival HR 0.19, 95% CI 0.05-0.70; p = 0.01 ...

Prostate cancer is the leading cancer type in men. Getting screened can help you catch cancer early, when it’s easier to ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

Prostate cancer is the second-leading cause of cancer death in American men. According to the American Cancer Society, Black ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...